Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (211-220 of 263) with videos related to

Pageof 27
Sort By:
Plos Neglected Tropical Diseases|November 28, 2017
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasisPedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, et al.
Oncogene|October 9, 2002
Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient seraCraig H Day, Gary R Fanger, Marc W Retter, et al.
Plos One|November 10, 2010
A synthetic adjuvant to enhance and expand immune responses to influenza vaccinesRhea N Coler, Susan L Baldwin, Narek Shaverdian, et al.
Vaccine|February 26, 2011
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidateSusana Lousada-Dietrich, Prajakta S Jogdand, Søren Jepsen, et al.
Vaccines|November 27, 2021
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An OverviewBruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes Dos Santos Fonseca, et al.
Plos One|October 22, 2015
Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in MacrophagesFabrícia Alvisi de Oliveira, Aline Silva Barreto, Lays G S Bomfim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2018
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against ZikaJesse H Erasmus, Amit P Khandhar, Jeff Guderian, et al.
Iscience|April 15, 2025
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaquesSevasti Karaliota, Maha Moussa, Margherita Rosati, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
BMC Infectious Diseases|September 24, 2015
Development and comparative evaluation of two antigen detection tests for Visceral LeishmaniasisAarthy C Vallur, Yeung L Tutterrow, Raodoh Mohamath, et al.
Pageof 27

Showing results (211-220 of 263) with videos related to

Sort By:
Pageof 27
Plos Neglected Tropical Diseases|November 28, 2017
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasisPedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, et al.
Oncogene|October 9, 2002
Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient seraCraig H Day, Gary R Fanger, Marc W Retter, et al.
Plos One|November 10, 2010
A synthetic adjuvant to enhance and expand immune responses to influenza vaccinesRhea N Coler, Susan L Baldwin, Narek Shaverdian, et al.
Vaccine|February 26, 2011
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidateSusana Lousada-Dietrich, Prajakta S Jogdand, Søren Jepsen, et al.
Vaccines|November 27, 2021
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An OverviewBruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes Dos Santos Fonseca, et al.
Plos One|October 22, 2015
Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in MacrophagesFabrícia Alvisi de Oliveira, Aline Silva Barreto, Lays G S Bomfim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2018
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against ZikaJesse H Erasmus, Amit P Khandhar, Jeff Guderian, et al.
Iscience|April 15, 2025
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaquesSevasti Karaliota, Maha Moussa, Margherita Rosati, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
BMC Infectious Diseases|September 24, 2015
Development and comparative evaluation of two antigen detection tests for Visceral LeishmaniasisAarthy C Vallur, Yeung L Tutterrow, Raodoh Mohamath, et al.
Pageof 27